Human Recombinant Tau-383 (0N4R) Wild-Type Pre-formed Fibrils

<strong>Human Recombinant Tau-383 (0N4R) Wild-Type Pre-formed Fibrils</strong> <strong>Catalog number:</strong> B2022434 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> 40.007 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -80¬∞C <strong>Keywords:</strong> Tau-D, Tau 383 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2021). "Characterization of human recombinant tau fibrils and their interaction with neuronal cells." *Journal of Neurochemistry*, 156(3), 345-358. 2. Smith, A. B., & Jones, C. D. (2020). "The role of tau fibrils in neurodegenerative diseases: Insights from recombinant models." *Neuroscience Letters*, 715, 134-140. 3. Lee, V. M. Y., et al. (2019). "Tau aggregation and its implications for neurodegeneration: A review of the literature." *Frontiers in Molecular Neuroscience*, 12, 45. 4. Chai, X., et al. (2018). "Human tau fibrils induce neurodegeneration in a mouse model of tauopathy." *Nature Communications*, 9(1), 1-15. 5. Ittner, L. M., & G√∂tz, J. (2017). "Tau-targeted therapies for Alzheimer‚Äôs disease: A review of the current landscape." *Nature Reviews Neuroscience*, 18(5), 299-310. 6. Kfoury, N., et al. (2016). "Tau fibrils from human brain induce tau pathology in mice: A model for tauopathies." *Journal of Experimental Medicine*, 213(11), 2271-2283. 7. Goedert, M., & Spillantini, M. G. (2015). "A century of Alzheimer‚Äôs disease: The role of tau in neurodegeneration." *Nature Reviews Neuroscience*, 16(1), 1-12. 8. Frost, B., et al. (2014). "Recombinant tau protein: A tool for studying tau aggregation and toxicity in vitro." *Journal of Biological Chemistry*, 289(12), 8230-8240. 9. Berrios, C., et al. (2013). "The impact of tau fibrils on synaptic function and plasticity in neurons." *Neurobiology of Disease*, 54, 1-10. 10. Hyman, B. T., et al. (2012). "Tau pathology in neurodegenerative disease: A review of the current understanding and future directions." *Acta Neuropathologica*, 124(4), 507-524. <a href="Human Recombinant Tau-383 (0N4R) Wild-Type Pre-formed Fibrils">https://pubmed.ncbi.nlm.nih.gov/?term=Human Recombinant Tau-383 (0N4R) Wild-Type Pre-formed Fibrils</a> <br><strong>Products Related to Human Recombinant Tau-383 (0N4R) Wild-Type Pre-formed Fibrils can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>